Moldova declares state of emergency over fears Russian gas flows via Ukraine will stop

Moldova declares state of emergency over fears Russian gas flows via Ukraine will stop


Dorin Recean, Moldova’s prime minister, speaks during the United Nations General Assembly (UNGA) in New York, US, on Friday, Sept. 27, 2024.

Bloomberg | Bloomberg | Getty Images

Moldova’s parliament on Friday voted to approve a 60-day state of emergency, citing fears of an immediate threat to the security of its citizens ahead of an expected halt in Russian gas flows.

Russian gas currently reaches Moldova, a landlocked country in the northeastern corner of Europe’s Balkan region, via its neighbor of Ukraine.

However, a gas transit deal between Russia’s Gazprom and Ukraine’s Naftogaz is set to expire on Dec. 31 and Kyiv has repeatedly said it has no intention to extend the contract.

A total of 56 lawmakers of Moldova’s 101-seat parliament voted in favor of a nationwide state of emergency, which the government said would allow the country to apply a series of measures to prevent and mitigate the threat of insufficient energy resources.

The cessation of Russian gas to Moldova’s Transnistrian region could generate “a humanitarian crisis” as well as “risks to the functioning and stability” of the country’s energy sector, according to a press release from Moldova’s parliament.

Moldova Prime Minister Dorin Recean said this winter must be the last in the country’s history that it can be held hostage over energy supplies.

Russia, which launched a full-scale invasion of Ukraine nearly three years ago, has previously said it stands ready to continue to supply gas to Europe via Ukraine.

A man exits the Moldovan Parliament building following reports from the Parliament’s Communication and Public Relations Department that its email server was compromised in a cyberattack on October 19, 2024 in Chisinau, Moldova.

Pierre Crom | Getty Images News | Getty Images

Analysts at Dutch bank ING said the cessation of Russian gas supplies into Europe via Ukraine means the European Union will lose around 15 billion cubic meters of gas supply annually, which is the equivalent to around 5% of total imports.

“While there have been some efforts to try to keep gas flowing through a possible swap with Azerbaijan, it appears that these flows will stop and we believe this should be priced into the market,” Warren Patterson, head of commodities strategy at ING, said in a research note published Wednesday.

“This leaves a downside risk to the market. If for any reason these flows continue, the European market will be left better supplied than many were expecting,” he added.



Source

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
World

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift […]

Read More
The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector
World

The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector

This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and […]

Read More
Novartis shells out  billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
World

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]

Read More